Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Maculopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05963646
What this trial is testing

Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyVisual Field Defect, Central Scotoma of Both Eyes
Institute of Molecular and Clinical Ophthalmology Basel 30
Large-scale testing (Phase 3)Study completedNCT02540954
What this trial is testing

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Macular Degeneration
Bayer 336
Testing effectiveness (Phase 2)Study completedNCT00447954
What this trial is testing

An Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

Who this might be right for
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Neurotech Pharmaceuticals 53
Not applicableStudy completedNCT01204541
What this trial is testing

A Single-Center Pilot Study to Assess Macular Function

Who this might be right for
Macular Degeneration
ORA, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01570790
What this trial is testing

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Combretastatin A4 PhosphateAge-related Macular DegenerationAMD+2 more
Johns Hopkins University 8
Not applicableStudy completedNCT06381596
What this trial is testing

Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
University of Wisconsin, Madison 32
Not applicableStudy completedNCT03509623
What this trial is testing

Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University Hospital of Patras 47
Not applicableActive Not RecruitingNCT04932980
What this trial is testing

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Berner Augenklinik 80
Not applicableStudy completedNCT03324542
What this trial is testing

Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

Who this might be right for
AMD
Changhua Christian Hospital 63
Not applicableStudy completedNCT00596388
What this trial is testing

Usage of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 20
Not applicableStudy completedNCT03878420
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 44
Large-scale testing (Phase 3)Study completedNCT02307682
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,775
Post-approval studies (Phase 4)Study completedNCT00751361
What this trial is testing

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

Who this might be right for
Dry Age Related Macular Degeneration
Apheresis Research Institute 52
Early research (Phase 1)WithdrawnNCT04919096
What this trial is testing

Study of SCB-420 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Clover Biopharmaceuticals AUS Pty
Not applicableStudy completedNCT02224963
What this trial is testing

Macular Degeneration and Aging Study

Who this might be right for
Age-related Macular Degeneration
University of Rochester 216
Post-approval studies (Phase 4)Study completedNCT01006538
What this trial is testing

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

Who this might be right for
Macular Degeneration
King's College Hospital NHS Trust 363
Testing effectiveness (Phase 2)Study completedNCT01972763
What this trial is testing

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.

Who this might be right for
Recalcitrant Wet Age-related Macular Degeneration
Northern California Retina Vitreous Associates 12
Not applicableLooking for participantsNCT07069647
What this trial is testing

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics

Who this might be right for
Age-Related Macular Degeneration (AMD)Diabetic Retinopathy (DR)
National Taiwan University Hospital 4,300
Not applicableStudy completedNCT01650948
What this trial is testing

Genetic Load and Phenotype in Aggressive AMD

Who this might be right for
Age-related Macular Degeneration
Sequenom, Inc. 100
Not applicableStudy completedNCT02951351
What this trial is testing

Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections

Who this might be right for
Age-related Macular DegenerationDiabetic Macular EdemaInjection Site+2 more
Mayo Clinic 36
Next Page